Ocular cicatricial pemphigoid

International Ophthalmology Clinics

Volumn 38, Issue 4, 1998, Pages 89-106

  Holsclaw, Douglas S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DAPSONE;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; EYE DISEASE; EYELID DISEASE; KERATOCONJUNCTIVITIS; KERATOPATHY; PATHOGENESIS; PEMPHIGOID; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TREATMENT PLANNING;

CONJUNCTIVAL DISEASES; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; DIAGNOSIS, DIFFERENTIAL; EYELID DISEASES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PROGNOSIS;

EID: 0032437859     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199803840-00009     Document Type: Review

References (82)

1. Hippocrates. Hippocrates popularium liber sixtus. In: JA, vander Linden ed. Opera omnia. Apud gaasbeekius, vol 1. 1665:798
2. Wichmann JE. Ideen zur Diagnostick, vol 1. Hannover: Helwing, 1793:89
3. von Graefe A. Berl Dtsch Ophthalmol Ges 1879;12:234
4. Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc 1986;84:527-663
5. Lever WF. Pemphigus and pemphigoid. J Am Acad Dermatol 1979;1:2
6. Lever WF. Pemphigus. Medicine 1953;32:1-123
7. von Kries N. Caustistiche Mittheilungen aus der Augenklinik zu Halle: V. Essential le Schrumpfung der Conjunctivia. Arch Ophthalmol 1878;24:157-158
8. Ahmed AR, Kurgis BS, Rogers RS III. Cicatricial pemphigoid. J Am Acad Dermatol 1991;24:987-1001
9. Bettekheim H, Kraft D, Zehetbauer G. Uber den sogenanneten Augenpemphigus (pemphigus ocularis; pemphigus conjunctivae). Klin Monatsbl Augenheilkd 1972; 160:65-75
10. Hardy WF, Lamb HD. Essential shrinking of the conjunctiva with report of two cases. Am J Ophthalmol 1917;34:289-299
11. Mondino BJ, Brown SI. Ocular cicatricial pemphigoid. Ophthalmology 1981;88:95-100
12. Mondino BJ. Cicatricial pemphigoid and erythema multiforme. Ophthalmology 1990;97:939
13. Iglesias LS, Quismorio FP Jr, McDonnell PJ, Barnes C. Ocular cicatricial pemphigoid in a twelve-year-old boy. Cornea 1992;4:365-367
14. Mondino BJ, Manthey R. Dermatological diseases and the peripheral cornea. Int Ophthalmol Clin 1986;26:121
15. Duke-Elder S, ed. System of ophthalmology: diseases of the outer eye. St Louis: Mosby, 1965: 236-252
16. Gazala JR. Ocular pemphigus. Am J Ophthalmol 1959;48:355
17. Mondino BJ, Brown SI, Lempert S, et al. The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology 1979;86:543-555
18. Heilegenhaus A, Shore JW, Rubin PAD, Foster CS. Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid. Ophthalmology 1993;1100:1283-1288
19. Rosser PM, Collin JRO. Retractor plication for lower lid entropion in ocular cicatricial pemphigoid. Aust NZ J Ophthalmol 1993;21:93-97
20. Shore JW, et al. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 1992;99:383-395
21. Foster CS, Wilson LA, Elkins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 1982;89:340-353
22. Pfluger E. Ueber pemphigus conjunctivae. Klin Monatsbl Augenheilkd 1878;16:1-18
23. Steffan XX. Pemphigus conjunctivae. Klin Monatsbl Augenheilkd 1885;23:214-216
24. Bernauer W, Wright P, Dart JK, et al. The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis. Ophthalmology 1993; 100:339-346
25. Hanson RD, Olsen KD, Rogers RS. Upper aerodigestive tract manifestations of cicatricial pemphigoid. Ann Otol Rhinol Laryngol 1988;97:493-499
26. Elder MJ, Bernauer W, Leonard J, Dart JKG. Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 1996;80:292-296
27. Brody HJ, Pirozzi DJ. Benign mucous membrane pemphigoid. Arch Dermatol 1977;113:1598-1599
28. Frith P, Charnock M, Wojnarowska F. Cicatricial pemphigoid diagnosed from ocular features in recurrent severe vulval scarring. Two case reports. Br J Obstet Gynaecol 1991;98:482-484
29. Shklar G, McCarthy PL. Oral lesions of mucous membrane pemphigoid: a study of 85 cases. Arch Otolaryngol 1971;93:354-364
30. Moschella SL, Pillsbury DM, Hurley HJ. Dermatology, vol 1. Philadelphia: Saunders, 1975:460-476
31. Bean SF. Cicatricial pemphigoid - immunofluorescent studies. Arch Dermatol 1974; 110:552-555
32. Bernauer W, Elder MJ, Leonard JN, et al. The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation. Graefes Arch Clin Exp Ophthalmol 1994;32:533-537
33. Furey N, West C, Andrews T, et al. Immunofluorescent studies of ocular cicatricial pemphigoid. Am J Ophthalmol 1975;80:825-831
34. Griffiths M, Fukuyama K, Tuffanelli D, Silverman S. Immunofluorescent studies in mucous membrane pemphigoid. Arch Ophthalmol 1974;109:195-199
35. Mondino BJ, Brown SI, Rabin BS. Autoimmune phenomena of the external eye. Ophthalmology 1978;85:801-817
36. Sacks EH, Jakobiec FA, Wieczorek R, et al. Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T cell-mediated disease. Ophthalmology 1989;96:236-243
37. Borradori L, Caldwell JB, Briggaman RA, et al. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995;11:590-595
38. Lazarova Z, Yee C, Darling T, et al. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996;98:1509-1518
39. Liu Z, Diaz LA, Troy JL, et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP 180. J Clin Invest 1993;92:2480-2488
40. Roat MI, Sossi G, Lo CY, Thoft RA. Hyperproliferation of conjunctival fibroblasts from patients with cicatricial pemphigoid. Arch Ophthalmol 1989;107:1064-1067
41. Balding SD, Prost C, Diaz LA, et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP 180 extracellular domain. J Invest Dermatol 1996;106:141-146
42. Bernard P, Prost C, Durepaire N, et al. The major cicatricial pemphigoid is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol 1992;99:174-179
43. Domloge-Hultsch N, Anhalt GJ, Gammon WR, et al. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol 1994;130:1521-1529
44. Kirtschig G, Marinkovich PM, Burgeson RE, Yancey KB. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 1995;105:543-548
45. Smith EP, Taylor TB, Meyer LJ, Zone JJ. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. J Invest Dermatol 1993;101:619-623
46. Ishihara M, Ishihara H, Hatano H, Ohno S. Two cases of cicatricial pemphigoid showing atypical immunofluorescent findings. Ann Ophthalmol 1991;23:434-438
47. Roat MI, Alstadt SP, Carpenter AB, et al. Antibasement membrane antibody-mediated experimental conjunctivitis. Invest Ophthalmol Vis Sci 1990;31:168-175
48. Andersen SR, Jensen OA, Kristensen EB, Norn MS. Benign mucous membrane pemphigoid: III. Biopsy. Acta Ophthalmol (Copenh) 1974;52:455-563
49. Frith P, Venning VA, Wojnarowska F, et al. Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study. Br J Ophthalmol 1989;73:52-56
50. Kinoshita S, Kiorpes TC, et al. Goblet cell density in ocular surface disease. Arch Ophthalmol 1983;101:1284-1287
51. Rice BA, Foster CS. Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990;97:1476-1483
52. Power WJ, Neves RA, Rodriguez A, et al. Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology 1995;102:1158-1163
53. Leonard JN, Haffenden GP, Ring NP, et al. Linear IgA disease in adults. Br J Dermatol 1982;107:301-316
54. Webster GF, Raber I, Penne R, et al. Cicatrizing conjunctivitis as a predominant manifestation of linear IgA bulous dermatosis. J Am Acad Dermatol 1994;30:355-357
55. Wojnarowska F, Allen J, Collier P, et al. Linear IgA disease: cylindroma demonstrates heterogeneity of the target antigens. Dermatology 1994;189(suppl 1):102-104
56. Perry HD. Vesiculobullous disease, sec 6-13. In: Deemis JD, ed. Clinical dermatology. New York: Harper & Row, 1985
57. Helander SD, Rogers RS. The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol 1994;30:65-75
58. Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication: II. The outcome of filtration surgery. Arch Ophthalmol 1994;112:1446-1454
59. Fiore PM, Jacobs IH, Goldberg DB. Drug-induced pemphigoid. Arch Ophthalmol 1987; 105:1660
60. Hirst LW, et al. Drug-induced cicatrizing conjunctivitis simulating ocular pemphigoid. Cornea 1982;1:121
61. Kremer I, Rozenbaum D, Aviel E. Immunofluorescence findings in pseudopemphigoid induced by short-term idoxuridine administration. Am J Ophthalmol 1991;111:375-377
62. Lass JH, Thoft RA, Dohlman CH. Idoxuridine-induced conjunctival cicatrization. Arch Ophthalmol 1979;101:747
63. Patten JT, Cavanagh HD, Allansmith MR. Induced ocular pseudopemphigoid. Am J Ophthalmol 1976;82:272-276
64. Pouliquen Y, et al. Drug-induced cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1986;93:775
65. Flach A. Symblepharon in sarcoidosis. Am J Ophthalmol 1978;85:210-214
66. Hemady R, Tauber J, Foster CS. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 1991;35:369-385
67. Mondino BJ, Brown SI. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 1983;96:453
68. Fern AI, Jay JL, Young H, MacKie R. Dapsone therapy for the acute inflammatory phase of ocular cicatricial pemphigoid. Br J Ophthalmol 1992;76:332-335
69. Neumann R, Tauber J, Foster CS. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology 1991;98:858-862
70. Rogers RS, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 1982;6:215
71. Tauber J, Sainz de la Maza M, Foster CF. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 1991;10:185-195
72. Elder MJ, Lightman S, Dart JKG. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol 1995;79:264-266
73. Dave VK, Vicker CFH. Azathioprine in the treatment of mucocutaneous pemphigoid. Br J Dermatol 1974;90:183-186
74. Mallon E, Wojnarowska F. Cicatricial pemphigoid presenting with unusual palmar involvement, successfully treated with a combination of nicotinamide and tetracycline. Clin Exp Dermatol 1994;19:526-530
75. Francis IC, McCluskey PJ, Walls RS, et al. Ocular cicatricial pemphigoid. Aust NZ J Ophthalmol 1990;18:143-150
76. Tauber J, Jabbur N, Foster CS. Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 1992;5:446-451
77. Schwab IR, Linberg JV, Gioia VM, et al. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 1992;99:197-202
78. Bartley GB, Lowry JC. Argon laser treatment of trichiasis. Am J Ophthalmol 1992;113:71-74
79. Elder MJ, Bernauer W. Cryotherapy for trichiasis in ocular cicatricial pemphigoid. Br J Ophthalmol 1994;78:769-771
80. Moshegov CN, Francis IC, Mulligan NB, Ross CA. Medial canthal keratinisation (MCK): a diagnostic sign of ocular cicatricial pemphigoid. Aust NZ J Ophthalmol 1992;20:350-351
81. Herbort CP, Weissman SS, Ostler HB, et al. Ocular surface keratinization as a predictor of response to topical retinoic acid therapy. Arch Ophthalmol 1989;107:1275-1276
82. Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 1995;102:576-585